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A b s t r A c t
We report a case of a previously healthy 26-year-old male, admitted to the intensive 
care unit due to cerebral edema. The patient was admitted 3 days earlier to the neu-
rological department because of sudden onset of headache and vision disturbances. 
Brain magnetic resonance imaging (MRI) on admission revealed an extended right 
parietooccipital lesion with marginal contrast enhancement and extension towards 
the corpus callosum. The patient quickly deteriorated, became comatose and was in-
tubated and transferred to the intensive care unit. In order to control intracranial 
hypertension, decompressive craniectomy was decided which also allowed for a brain 
biopsy. According to clinical, radiological and laboratory data, acute disseminated 
encephalomyelitis was the working diagnosis. The patient was treated with high dose 
corticosteroids and plasmapheresis sessions and gradually improved and transferred 
to a rehabilitation center. Brain biopsy showed acute hemorrhagic leukoencephalitis 
or Hurst disease, a variant of acute disseminated encephalomyelitis.
I N t r O D U c t I O N
Acute fulminant brain dysfunction may derive from infectious, inflammatory, 
vessel-obstructive, vessel-inflammatory, demyelinating, neoplastic, metabolic or toxic 
processes. Causative spectrum is quite wide to be timely worked up when danger for 
life is present. Clinical evaluation, blood testing, brain computed tomography and 
lumbar puncture constitute the standard emergency diagnostic sequence. From the 
physician’s perspective, narrowing the differential diagnosis to subgroups of entities 
with common treatment plan is highly desirable. Early recruitment of detailed brain 
imaging, i.e., brain parenchyma magnetic resonance imaging (MRI) together with 
arteriography and venography protocols (MRA, MRV) should be viewed as manda-
tory in this context.1,2 On the contrary, specific laboratory investigations in blood and 
cerebrospinal fluid are often either not available or not informative in the early stage. 
In cases with ambiguous findings, targeted brain biopsy always remains an option.1,3,4
cAse repOrt
1Department of Critical Care Medicine 
and Pulmonary Services,  
2Department of Neurology,  
3Department of Neurosurgery, 
4Laboratory of Pathology,  
Evagelismos Hospital, Athens, Greece
HOSPITAL CHRONICLES 2014, 9(3): 202–207
Correspondence to:
Adamantia Sotiriou, MD,  
Critical Care Medicine, Evagelismos 
Hospital, Athens, Greece;  
E-mail: mandiasotiriou@hotmail.com
Manuscript received September 25, 2013; 
Revised manuscript received January 23, 
2014; Accepted March 21, 2014
Key wOrDs: acute disseminated 
leukoencephalitis; decompressive 
craniectomy; Hurst disease; cerebral 
edema; epileptic seizures; multiple 
sclerosis
AbbreviAtions
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encephalomyelitis
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CRP = C reactive protein
FLAIR = fluid attenuated inversion 
recovery
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HLA = human leukocyte antigen
ICU = intensive care unit
MRA = magnetic resonance arteriography
MRI = magnetic resonance imaging
MRV = magnetic resonance venography
PML = progressive multifocal 
leukoencephalopathy
SV 40 = Simian virus 40
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c A s e  r e p O r t
A 26-year-old previously healthy male patient was admit-
ted via the Emergency Department complaining for severe 
headache and vision disturbances.
Medical history was remarkable for post infectious cer-
ebellar dysfunction at the age of 7 years, aphthous stomatitis 
the previous year, and nasal congestion with myalgias 20 days 
earlier. Family history revealed the presence of non-Hodgkin 
lymphoma in his sister.
The patient reported abrupt onset of occipital headache 
and diplopia 3 hours prior to his admission. Clinical examina-
tion at the emergency room revealed right hemianopsia and 
positive left Babinski sign. There was no fever, nor nuchal rigid-
ity. White blood cell count was 10.200*103/μl with lymphopenia 
and C-reactive protein (CRP) was 0.2 mg/dl. A brain computed 
tomography revealed cerebral edema localized in the right 
parietooccipital region without contrast enhancement. There 
was no midline shift; funduscopic examination showed absence 
of optic disc edema; clinical sings of “impeding” herniation 
were not evident and a lumbar puncture was safely undertaken. 
Opening pressure was 4 cm H
2
O and cell count, glucose and 
protein were 4 per mm3, 60 mg/dl (plasma glucose: 69 mg/dl) 
and 54 mg/dl, respectively. The patient was admitted to the 
Neurology Department.
The following day, headache was limited to the right 
retrobulbar area. General irritability, focal tonic-clonic sei-
zures of the left upper limb and left hemiplegia sequentially 
emerged. Electroencephalogram was positive for focal brain 
dysfunction in the temporoparietal region (Table 2). Brain 
MRI (Fig. 1) revealed an extended right parietooccipital 
lesion with low signal on T1 sequence and high signal on T2 
and FLAIR sequences, with marginal contrast enhancement 
and extension towards the corpus callosum. A second smaller 
lesion was identified in front of the first. Despite dexametha-
sone and valproic acid therapy, the patient sank gradually into 
coma and developed right mydriasis. He got intubated during 
the third day and a new brain computed tomography showed 
diffuse cerebral and brainstem edema. The patient was then 
transferred to the intensive care unit (ICU). Neurosurgical 
consultation suggested intraventricular catheter placement for 
intracranial pressure monitoring. First value was 60 mmHg. 
Decompressive right hemicraniectomy was undertaken. The 
ICU physician requested a brain biopsy sample.
Intracranial pressure was alleviated with surgery, but brain 
computed tomography images were still disappointing after 
days. Neurology consultant gave priority to acute disseminated 
encephalomyelitis as the working diagnosis. Clinical, radiologi-
cal and laboratory data (Tables 1 & 2) were consistent with 
such a diagnosis. Tailored to this initial diagnosis, the patient 
received pulse dose of methyloprednisolone 1 g/day. After 5 
days patient was switched to prednisone 1 mg/kg along with 
daily sessions of plasmapheresis, because of persistent cerebral 
edema. Additional treatment with antimicrobials (ceftriaxone, 
vancomycin, trimethoprim-sulfamethoxazol, azithromycin) 
and ganciclovir for three weeks was also provided. Histology 
report, available on the 20th day, made mention of the pres-
ence of immunohistochemic positivity for anti-Simian Virus 
40 (SV40) antibody, but the concluded diagnosis was acute 
hemorrhagic leukoencephalitis (Fig. 2).
Gradual sedation withdrawal revealed a Glasgow Coma 
Scale (GCS) of 15, with left hemiplegia. Sedative drugs were 
continued until day 10. As protracted ICU stay was anticipated, 
the patient underwent early tracheostomy and gastrostomy. 
MRI follow-up on the 30th day disclosed brain lesion downsiz-
ing. After weaning from mechanical ventilation and completing 
20 plasmapheresis sessions on the 45th day from admission, the 
patient was transferred to the intermediate care department. 
During the next 3 months, corticosteroids were gradually ta-
pered and bone flap was restored. After another 3 months with 
physiotherapy and speech therapy, he got rid of tracheostomy 
FIgUre 1. brain MrI on admission. A: Extensive parenchymal 
lesion right parietooccipitally with inhomogenous signal in T2 
and FLAIR sequences and low signal in T1 sequence. Marginal 
contrast enhancement and extension through the corpus callo-
sum. b: Second little lesion with contrast enhancement in front 
of the main one. FLAIR = fluid attenuated inversion recovery; 
MRI = magnetic resonance imaging.
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tAble 1. Laboratory Findings
blood chemistries
Glucose 69 mg/dl Uric acid 4.8 mg/dl
Urea 44 mg/dl AST / ALT 19 IU/l/25 IU/l
Creatinine 1.03 mg/dl Alkaline phosphatase 66 IU/l
Amylase 41 IU/l γGT 12 IU/l
Total protein 7.43 g/dl Bilirubin 0.68 mg/dl
Albumin 4.8 g/dl Creatine kinase (Ck) 78 IU/L
Globulins 2.63 g/dl Ck-MB 19 IU/l
Potassium 4.6 mmol/l Lactic dehydrogenase 169 IU/l
Calcium 9.6 mg/dl Cholesterol 196 mg/dl
Phosphorus 4.58 mg/dl Triglycerides 70 mg/dl
Magnesium 2.06 mg/dl C-reactive protein 0.2 mg/dl
Iron 46 μg/dl ESR 14 mm/h
blood counts
Complete blood count lymphopenia
White blood cell count 11.6*103/μl
Neutrophils (%) 72%
Lymphocytes (%) 20.7%
Monocytes (%) 6.45%
Red blood cell count 6.32*106/μl
Hematocrit 46.7%
Hemoglobin 16.2 g/dl
Platelet count 217*103/μl
Autoimmune disorders
Antinuclear antibodies (ANA) negative
Antineutrophil cytoplasmic antibodies (ANCA) negative
AntidsDNA antibodies negative
Anti-cardiolipin antibodies (ACA) negative
Cryoglobulins negative
Anti acquaporin 4 negative
Human leucocyte antigen (HLA) B51 positive
Muscle/vessel/skin biopsy negative
Infectious agents
Fluorescent antibody tests for viruses: HSV, CMV, VZV, EBV, Echo, Coxsackie, Adenovirus,  
Influenza A, B, measles, mumps, rubella
negative
Fluorescent antibody tests for bacteria: Listeria, Borrelia, Coxiella, Chlamydia, Mycoplasma, Legionella negative
Human immunodeficiency virus (HIV) (Western blot and PCR) negative
blood disorders
Τhrombofilia negative
Bone marrow aspirate reactive
Peripheral blood immunophenotyping Lymphopenia, no clonicity
Bone marrow immunophenotyping Lymphopenia, no clonicity
Flow cytometry for NPH negative
Immunoelectrophoresis negative
Cold agglutinins 1:256
cerobrospinal fluid examination
Cells, protein, glucose (1) day 1 4/cm³, 54 mg/dl, 60 mg/dl
Cells, protein, glucose (2) day 3 50/cm³, 152 mg/dl, 60 mg/dl
Cells, protein, glucose (3) day 22 2/cm³, 54 mg/dl, 90 mg/dl
Gram stain-culture negative
Ziel Nielsen stain-culture negative
PCR: JCV, HSV, EBV, VZV, Enterovirus, West Nile Virus, Toxoplama, Coxiella negative
PCR for Cytomegalovirus 25 copies/μl
Oligoclonal bands negative
Cryptococcus antigen negative
Immunoelectrophoresis Possible IgG production
ALT: alanine transaminase; AST: aspartate transaminase; CMV: cytomegalovirus; EBV: Epstein-Barr virus; ESR: erythrocyte sedimentation rate; HSV: 
herpes simplex virus; JCV: John Cunningham virus; NPH: noctural paroxysmal hemoglobinuria; PCR: polymerase chain reaction; VZV: Varicella zoster virus.
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and gastrostomy and was finally referred to a rehabilitation 
center. One year post-admission the patient was able to read, 
speak and walk with minimal help.
D I s c U s s I O N
Acute disseminating encephalomyelitis is a rare clinical 
entity affecting mainly children and related to recent infections 
or vaccinations. Pathogenesis is related to activation of T-cells 
with neuro-crossreacting antigens, passage of T-cells through 
the perivenular space towards oligodendroglial dendritic cells 
for further antigen processing along with human leukocyte 
tAble 2. Imaging, Paraclinical and Histological Findings
Computed tomography(1) day 1 Right parietooccipital edema, no contrast enhancement
Computed tomography(2) day 3 Diffuse hypodense appearance in brain hemispheres and brain stem, midline shift to the left, probable 
herniation through the tentorium
Computed tomography(3) day 10 Diffuse hypodense appearance in brain hemispheres and brain stem, absence of midline shift
Magnetic resonance(1) day 2 Extensive parenchymal lesion right parietooccipitally with inhomogenous signal in T2 and FLAIR 
sequences and low signal in T1 sequence. Marginal contrast enhancement and extension along the 
corpus callosum. Second little lesion with contrast enhancement in front of the main one. 
Magnetic resonance (2) day 30 Right hemicraniectomy and right ventricle dilatation. Large confluent area of T2 hyperintensity 
located in the white matter of right parietoccipital lobes and corpus callosum splenium. Downsizing 
of the area in comparison to previous imaging. Moderate ring contrast enhancement is still observed.
Cerebral angiography day 4 negative
Electroencephalogram day 2 High voltage activity in the right temporoparietal region
U/S cervical vessels day 2 negative
Fundoscopy day 1 negative
Brain biopsy day 3 Perivenular inflammatory infiltration with polymorphs, macrophages, perivenular hemorrhagic 
infiltration, perivenular myelinolysis, staining of oligodendroglia with SV40 antibody
FLAIR = fluid attenuated inversion recovery; SV40 = Simian virus 40; U/S = ultrasound
FIgUre 2. Histology, (a): Perivascular inflammation-perivenular lymphocytic infiltration (H+E x100); (b): Perivascular demyelina-
tion (arrows) (kluver Barrera x 200); (c): Nuclear immunohistochemic positivity of oligodendrocytes to SV-40 antibody (DAB x 400)
A Β c
antigen molecules, inflammatory cell confluence in the brain 
and local production of direct neurotoxic substances, leading 
to variable degrees of myelinolysis.5,6
While children present with encephalopathy (i.e. acute 
behavioural change or alteration in consciousness) which 
has been established as a major criterion for diagnosis, initial 
symptoms in young adults usually imitate those of multiple 
sclerosis. Indeed, acute disseminated encephalomyelitis 
(ADEM) is considered to be the multiple sclerosis monophasic 
equivalent. Time to maximum intensity is usually between 2 
and 7 days. Lumbar puncture and laboratory investigations are 
nonspecific. MRI of the brain is the investigation of choice and 
typically reveals more than one, asymmetrical, poorly margin-
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ated lesions, settled in the deep white matter. T2 and FLAIR 
sequences are more helpful than T1.6-8 Differential diagnosis in 
the typical case includes the group of demyelinating conditions 
(i.e., acute multiple sclerosis, neuromyelitis optica, transverse 
myelitis).6,9 Treatment with high doses of corticosteroids 
(pulse therapy) accompanied by immunoglobulin, in cases 
with impossible to define or suboptimal response, usually are 
adequate for all forms of demyelinating diseases.7,10,11 Active 
disease lasts 2-4 weeks and gradually resolves. Prognosis is 
favourable for acute survivors.
ADEM diagnosis is sufficiently set with clinical and 
radiological criteria.12,13 Biopsy is not usually conducted 
since there are no detailed histopathological guidelines for 
unequivocal establishment of diagnosis.14 The histologic 
hallmark is a perivenous mixed cell type inflammation along 
with myelinolysis. Location of lesions is highly sensitive for 
distinction against multiple sclerosis, but not exclusive as a 
finding.15 Biopsy in our case was performed in order to take 
advantage of the hemicraniectomy, because diagnosis was at 
that time uncertain. Brain biopsy substantially contributed to 
the required quick exclusions, but also it was an important 
auxiliary tool for verifying the diagnosis. However, waiting for 
the definite histological diagnosis to decide the appropriate 
treatment would have been a pitfall.14
The hemorrhagic or hyperacute variant of ADEM is called 
acute hemorrhagic leukoencephalitis (AHLE) or Hurst dis-
ease, described first in 1941 and reproduced experimentally in 
2008.16 Basic histological particularities compared to ADEM 
are dominance of polymorphs in the inflammatory infiltrates, 
more vessel damage and less myelinolysis, the basic elements 
though being preserved.17 Interestingly, this condition seems to 
resemble more neuromyelitis optica, except that its diagnosis 
does not require myelitis and eosinophils are not abundant in 
histology.9 Hemorrhagic lesion transformation is sometimes 
evident in MRI.2 In the case of AHLE, treatment intensity is 
maximised, adding prednisone 1 mg/kg after methylopredni-
solone pulses and recruiting early plasmapheresis sessions.18 
Prognosis is, by all means, guarded.2,19 Our patient was iden-
tified initially as usual ADEM and finally was ascertained 
histologically to fall into the hemorrhagic variant. By that time, 
treatment intensification had been implemented and clinical 
response had already been achieved.
Presence of anti SV40 antibody in oligodendroglial cells 
was an intriguing parallel finding. This feature awaits to be 
further elucidated by clinical follow-up as well as ongoing re-
search in the fields of tumorigenic action of SV40 or properties 
of polyoma viruses, which share 70% DNA homology between 
each other.20,21 Progressive multifocal leukoencephalopathy 
(PML), relating also to this group of viruses was readily ruled 
out because the patient was not formally immunosuppressed.22 
Relationship of SV-40 to multiple sclerosis could moreover be 
interesting,23 as the age of the patient and the involvement of 
optic nerve are mentioned as predisposing factors for future 
demyelinating events.7 Moreover, there exists a possibility of a 
random finding, as 3-5% of population in some countries are 
seropositive for the antibody,24 as also are 7% of brain biopsies 
in normal human controls.25
c O N c l U s I O N
Acute hemorrhagic leukoencephalitis has a mortality of at 
least 25%,10 often necessitating decompressive surgery.10,26,27 
This is a death obliterating procedure but reversal of patho-
physiology can be accomplished only through adequate immu-
nosuppression. Both medical and surgical therapies were ap-
plied in our case, because fast clinical deterioration portended 
a dismal outcome. Along with clinical criteria- based approach, 
brain MRI was highly supporting ADEM because of selective 
devouring of the white matter. Additional identification of 
the AHLE variant via histology came to legitimize maximal 
therapeutic arrangements initially undertaken on the basis of 
a clinical emergency. Short and intermediate clinical course 
pursued as anticipated. Hyperacute post infectious encephalitis 
was thus thoroughly documented and successfully treated. A 
5-year follow up is further required to authenticate diagnosis.7
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